SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond
Philosophical Transactions of the Royal Society B: Biological Sciences · 19.06.2023 · 378 (1879)
DOI: 10.1098/rstb.2022.0164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, 2023-05. Verfasst von Carol Ann Remme. Beteiligte Einrichtung: Department of Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam UMC location AMC, Univ…. Hauptthemen laut MEDLINE: Channelopathies, Cardiomyopathies, Epilepsy. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Netherlands Organisation for Health Research and Development, Netherlands CardioVascular Research Initiative, Fondation Leducq.
Abstract (Originalsprache)
Influx of sodium ions through voltage-gated sodium channels in cardiomyocytes is essential for proper electrical conduction within the heart. Both acquired conditions associated with sodium channel dysfunction (myocardial ischaemia, heart failure) as well as inherited disorders secondary to mutations in the gene SCN5A encoding for the cardiac sodium channel Nav1.5 are associated with life-threatening arrhythmias. Research in the last decade has uncovered the complex nature of Nav1.5 distribution, function, in particular within distinct subcellular subdomains of cardiomyocytes. Nav1.5-based channels furthermore display previously unrecognized non-electrogenic actions and may impact on cardiac structural integrity, leading to cardiomyopathy. Moreover, SCN5A and Nav1.5 are expressed in cell types other than cardiomyocytes as well as various extracardiac tissues, where their functional role in, e.g. epilepsy, gastrointestinal motility, cancer and the innate immune response is increasingly investigated and recognized. This review provides an overview of these novel insights and how they deepen our mechanistic knowledge on SCN5A channelopathies and Nav1.5 (dys)function. This article is part of the theme issue ‘The heartbeat: its molecular basis and physiological mechanisms’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Carol Ann Remme
Förderung
- Netherlands Organisation for Health Research and Development
- Netherlands CardioVascular Research Initiative
- Fondation Leducq
Zitieren
APA
Remme, C. A. (2023). SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond. Philosophical Transactions of the Royal Society B: Biological Sciences, 378(1879). https://doi.org/10.1098/rstb.2022.0164
Vancouver
Remme CA. SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond. Philosophical Transactions of the Royal Society B: Biological Sciences. 2023;378(1879). doi:10.1098/rstb.2022.0164
BibTeX
@article{Remme2023,
author = {Remme, Carol Ann},
title = {SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond},
journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
year = {2023},
volume = {378},
number = {1879},
doi = {10.1098/rstb.2022.0164}
}
EUVIMED